US Patent Number

7842493

Publication Date

11-30-2010

Abstract

It is the object of the current invention to provide methods and compositions relating to the expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production. The inventors have discovered that the expression of P-ank-1 and I2-ank-3 proteins in cell culture has increased the cells' longevity and capacity for endogenous and/or heterologous target protein production. Specifically, the present invention relates to the enhanced expression of endogenous and/or heterologous target proteins/polypeptides in recombinant cells that are also expressing P-ank-1 and/or I2-ank-3 protein compared to expression host cells that are not expressing P-ank-1 and/or I2-ank-3 protein.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

12/566,155

Filing Date

09/24/2009

Download

Included in

Entomology Commons

Share

COinS